Sunwoda Joins 2026 Sungrow Global Partners Conference to Deepen Global Collaboration and Sustainability

Sunwoda Joins 2026 Sungrow Global Partners Conference to Deepen Global Collaboration and Sustainability

HEFEI, China, Jan. 8, 2026 /PRNewswire/ -- On January 8, Sunwoda, as a global partner of Sungrow, attended the 2026 Sungrow Global Partners Conference in Hefei, Anhui Province, to discuss international expansion and sustainable development. Wang...

Samsung Highlights How Open Ecosystems Unlock the Real Promise of Home AI at CES 2026

Samsung Highlights How Open Ecosystems Unlock the Real Promise of Home AI at CES 2026

Samsung begins its CES 2026 Tech Forums by convening leaders in smart home interoperability for an industry-defining discussion LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- Samsung Electronics Co., Ltd. today convened leaders across industries in to...

Squirrel Ai's Dr. Liang Takes the Stage at Web Summit: Pioneering a New Human-AI Collaborative Paradigm for the Classroom of the Future

Squirrel Ai's Dr. Liang Takes the Stage at Web Summit: Pioneering a New Human-AI Collaborative Paradigm for the Classroom of the Future

SHANGHAI, Dec. 11, 2025 /PRNewswire/ -- From November 10 to 13, 2025, Web Summit, one of the world's premier technology events, was held at the MEO Arena in Lisbon, Portugal. This year's summit brought together more than 70,000 technology...

Uxin to Report Third Quarter 2025 Financial Results on December 18, 2025

Uxin to Report Third Quarter 2025 Financial Results on December 18, 2025

BEIJING, Dec. 12, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced that it will release its financial results for the third quarter 2025 ended September 30, 2025, before...

Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight

Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight

- ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss. - ASC30 titrated weekly to target dose demonstrated...

Over 400 domestic and international guests gathered at the 2025 Shandong Provincial Conference on Green, Low-Carbon, and High-Quality Development

Over 400 domestic and international guests gathered at the 2025 Shandong Provincial Conference on Green, Low-Carbon, and High-Quality Development

YANTAI, China, Dec. 5, 2025 /PRNewswire/ -- This is a report from the Shandong Office of Hong Kong Business Daily. On December 4, the 2025 Shandong Province Green, Low-Carbon, and High-Quality Development Conference was held in Yantai. The...

New TayaGel® Modus expands Jungbunzlauer's texturant portfolio

New TayaGel® Modus expands Jungbunzlauer's texturant portfolio

- A new era in gellan gum innovation delivers crystal-clear gels with very high gel strength, sustainably- BASEL, Switzerland, Dec. 2, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable ingredients from natural sources,...

DIGITIMES ASIA: AI workload surge creates opening for alternative memory and chiplet technologies, expert says

DIGITIMES ASIA: AI workload surge creates opening for alternative memory and chiplet technologies, expert says

TAIPEI, Dec. 2, 2025 /PRNewswire/ -- The rapid expansion of artificial intelligence (AI) workloads is forcing a fundamental redesign of data center infrastructure, driving historic memory shortages and opening a rare market window for alternative...

Hong Kong to Host International Summit on Heart and Brain Health, Spotlighting AI and Startup Innovations

Hong Kong to Host International Summit on Heart and Brain Health, Spotlighting AI and Startup Innovations

HONG KONG, Nov. 25, 2025 /PRNewswire/ -- The 2nd International Cerebro-cardiovascular Medical Innovation Summit (ICMIS 2025) will bring together global leaders to discuss cutting-edge research, innovative medical products, and cross-border...

Cango Inc. to Report Third Quarter 2025 Financial Results on December 1, 2025, Eastern Time

Cango Inc. to Report Third Quarter 2025 Financial Results on December 1, 2025, Eastern Time

DALLAS, Texas, Nov. 25, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that it plans to release its third quarter 2025 financial results after the market closes on Monday, December 1, 2025. The earnings...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 12
  • menu
    menu